QUOTE AND NEWS
Market Intelligence Center  6 hrs ago  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 5.40% return in just 51 days. Sell one Oct. '14 call at the $92.50 level for each 100 shares...
SeekingAlpha  Aug 12  Comment 
ByDoctoRx: Background: A year ago, United Therapeutics (NASDAQ:UTHR) came out with a strong quarterly earnings report, and I wrote a bullish article on it titled United Therapeutics - A Low PE, Fast-Growing Biotech Stock. Since then, the stock...
Market Intelligence Center  Jul 31  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 4.53% return in just 51 days. Sell one Sep. '14 call at the $92.50 level for each 100 shares...
SeekingAlpha  Jul 29  Comment 
United Therapeutics (NASDAQ:UTHR) Q2 2014 Earnings Call July 29, 2014 9:00 am ET Executives Martine A. Rothblatt - Founder, Chairman and Chief Executive Officer Roger A. Jeffs - President, Chief Operating Officer and Director ...
Market Intelligence Center  Jul 29  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on United Therapeutics (UTHR) that includes 8.15% downside protection. Sell one contract of the...
Market Intelligence Center  Jul 24  Comment 
After closing Wednesday at $93.78, United Therapeutics (UTHR) presents an attractive opportunity to get a 5.02% return in just 58 days, which is an annualized return of 31.58% (for comparison purposes only). To enter this trade, sell one Sep. '14...
FiercePharma  Jul 1  Comment 
A few weeks ago, we published our annual list of highest-paid biopharma CEOs. Now, we're saying whoops! Sitting at the top of our list was Regeneron CEO Leonard Schleifer with $36.27 million in 2013 compensation. But United Therapeutics chief...
Motley Fool  Jun 27  Comment 
Today's top stories in health care and biotech.
Market Intelligence Center  Jun 25  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on United Therapeutics (UTHR) that includes 6.72% downside protection. Sell one contract of the...
Market Intelligence Center  Jun 23  Comment 
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on United Therapeutics (UTHR). Look at the Aug. '14 $82.50 covered call for a net debit in the $78.76 area. This trade has a...





You may also be interested in articles related to United Therapeutics (UTHR):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki